Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005–2015

por Pradipta, Ivan S., van’t Boveneind-Vrubleuskaya, Natasha, Akkerman, Onno W., Alffenaar, Jan-Willem C., Hak, Eelko
Publicado 2019

Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment

por Keutzer, Lina, Mockeliunas, Laurynas, Sturkenboom, Marieke G. G., Bolhuis, Mathieu S., Akkerman, Onno W., Simonsson, Ulrika S. H.
Publicado 2023

Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis

por Mockeliunas, Laurynas, Keutzer, Lina, Sturkenboom, Marieke G. G., Bolhuis, Mathieu S., Hulskotte, Lotte M. G., Akkerman, Onno W., Simonsson, Ulrika S. H.
Publicado 2022

Eradication of Burkholderia cepacia complex in cystic fibrosis patients with inhalation of amiloride and tobramycin combined with oral cotrimoxazole

por Akkerman-Nijland, Anne M., Rottier, Bart L., Holstein, Joanne, Winter, Rik L.J., Touw, Daniel J., Akkerman, Onno W., Koppelman, Gerard H.
Publicado 2023

Sensitivity and specificity of an electronic nose in diagnosing pulmonary tuberculosis among patients with suspected tuberculosis

por Saktiawati, Antonia M. I., Stienstra, Ymkje, Subronto, Yanri W., Rintiswati, Ning, Sumardi, Gerritsen, Jan-Willem, Oord, Henny, Akkerman, Onno W., van der Werf, Tjip S.
Publicado 2019

Corticosteroid therapy for the management of paradoxical inflammatory reaction in patients with pulmonary tuberculosis

por Done, Macky M., Akkerman, Onno W., Al-Kailany, Wud, de Lange, Wiel C. M., de Jonge, Gonda, Kleinnijenhuis, Johanneke, Stienstra, Riejanne, van der Werf, Tjip S.
Publicado 2020

Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients

por Hoppentocht, Marcel, Akkerman, Onno W., Hagedoorn, Paul, Alffenaar, Jan-Willem C., van der Werf, Tjip S., Kerstjens, Huib A. M., Frijlink, Henderik W., de Boer, Anne H.
Publicado 2016

Eradication of Pseudomonas aeruginosa in cystic fibrosis patients with inhalation of dry powder tobramycin

por Akkerman-Nijland, Anne M., Yousofi, Mina, Rottier, Bart L., Van der Vaart, Hester, Burgerhof, Johannes G. M., Frijlink, Henderik W., Touw, Daan J., Koppelman, Gerard H., Akkerman, Onno W.
Publicado 2020

High Prevalence of Infectious Diseases and Drug-Resistant Microorganisms in Asylum Seekers Admitted to Hospital; No Carbapenemase Producing Enterobacteriaceae until September 2015

por Ravensbergen, Sofanne J., Lokate, Mariëtte, Cornish, Darren, Kloeze, Eveline, Ott, Alewijn, Friedrich, Alex W., van Hest, Rob, Akkerman, Onno W., de Lange, Wiel C., van der Werf, Tjip S., Bathoorn, Erik, Stienstra, Ymkje
Publicado 2016

Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial

por Espinosa-Pereiro, Juan, Ghimire, Samiksha, Sturkenboom, Marieke G. G., Alffenaar, Jan-Willem C., Tavares, Margarida, Aguirre, Sarita, Battaglia, Arturo, Molinas, Gladys, Tórtola, Teresa, Akkerman, Onno W., Sanchez-Montalva, Adrian, Magis-Escurra, Cecile
Publicado 2022

Variability and cost implications of three generations of the Roche LightCycler® 480

por Dullaert-de Boer, Maria, Akkerman, Onno W., Vermeer, Marloes, Hess, Dorine L. J., Kerstjens, Huib A. M., Anthony, Richard M., van der Werf, Tjip S., van Soolingen, Dick, van der Zanden, Adri G. M.
Publicado 2018

Correction: Variability and cost implications of three generations of the Roche LightCycler® 480

por Dullaert-de Boer, Maria, Akkerman, Onno W., Vermeer, Marloes, Hess, Dorine L. J., Kerstjens, Huib A. M., Anthony, Richard M., van der Werf, Tjip S., van Soolingen, Dick, van der Zanden, Adri G. M.
Publicado 2018

Corrigendum to “Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs” [Clin. Mass Spectrom. 14(Part A) (2019) 34–45]

por Kuhlin, Johanna, Sturkenboom, Marieke G.G., Ghimire, Samiksha, Margineanu, Ioana, van den Elsen, Simone H.J., Simbar, Noviana, Akkerman, Onno W., Jongedijk, Erwin M., Koster, Remco A., Bruchfeld, Judith, Touw, Daan J., Alffenaar, Jan-Willem C.
Publicado 2022

Malnutrition assessment methods in adult patients with tuberculosis: a systematic review

por ter Beek, Lies, Bolhuis, Mathieu S, Jager-Wittenaar, Harriët, Brijan, René X D, Sturkenboom, Marieke G G, Kerstjens, Huib A M, de Lange, Wiel C M, Tiberi, Simon, van der Werf, Tjip S, Alffenaar, Jan-Willem C, Akkerman, Onno W
Publicado 2021

Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis

por Akkerman, Onno W., Grasmeijer, Floris, de Lange, Wiel C.M., Kerstjens, Huib A.M., de Vries, Gerard, Bolhuis, Mathieu S., Alffenaar, Jan-Willem, Frijlink, Henderik W., Smith, Grace, Gajraj, Roger, de Zwaan, Rina, Hagedoorn, Paul, Dedicoat, Martin, van Soolingen, Dick, van der Werf, Tjip S.
Publicado 2018

Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study

por Henriette Zweijpfenning, Sanne Maria, Chiron, Raphael, Essink, Sharon, Schildkraut, Jodie, Akkerman, Onno W., Aliberti, Stefano, Altenburg, Josje, Arets, Bert, van Braeckel, Eva, Delaere, Bénédicte, Gohy, Sophie, Haarman, Eric, Lorent, Natalie, McKew, Genevieve, Morgan, Lucy, Wagner, Dirk, van Ingen, Jakko, Hoefsloot, Wouter
Publicado 2022

The effect of COVID-19 on transplant function and development of CLAD in lung transplant patients: A multicenter experience

por Roosma, Elizabeth, van Gemert, Johanna P., de Zwart, Auke E.S., van Leer-Buter, Coretta C., Hellemons, Merel E., Berg, Elize M., Luijk, Bart, Hoek, Rogier A.S., van Kessel, Diana A., Akkerman, Onno W., Kerstjens, Huib A.M., Verschuuren, Erik A.M., Gan, C. Tji
Publicado 2022

Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q

por Niewold, Paula, Dijkstra, Douwe J., Cai, Yi, Goletti, Delia, Palmieri, Fabrizio, van Meijgaarden, Krista E., Verreck, Frank A. W., Akkerman, Onno W., Hofland, Regina W., Delemarre, Eveline M., Nierkens, Stefan, Verheul, Marije K., Pollard, Andrew J., van Dissel, Jaap T., Ottenhoff, Tom H. M., Trouw, Leendert A., Joosten, Simone A.
Publicado 2023

Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis

por Delemarre, Eveline M., van Hoorn, Laura, Bossink, Aik W. J., Drylewicz, Julia, Joosten, Simone A., Ottenhoff, Tom H. M., Akkerman, Onno W., Goletti, Delia, Petruccioli, Elisa, Navarra, Assunta, van den Broek, Brigitte T. A., Paardekooper, Sanne P. A., van Haeften, Ineke, Koenderman, Leo, Lammers, Jan-Willem J., Thijsen, Steven F. T., Hofland, Regina W., Nierkens, Stefan
Publicado 2021